<p style="text-align:justify;" class="MsoNormal">Pfizer, which owns a 32% stake in Haleon Plc, said Monday it plans to cut its ownership in the consumer-healthcare business to about 24% by selling 630 million ordinary shares to institutional investors within the US and outside. </p>
